Akèy › Kansè poumon › Oregon › Eugene
Etid klinik pou Kansè poumon nan Eugene, OR
5 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Eugene (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Ap rekriteFaz 3
- Oncology Associates of Oregon PC, Eugene
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- USO - Oncology Associates of Oregon, Eugene
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Ap rekriteFaz 1
- USOR - Oncology Associates of Oregon, P.C, Eugene
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Ap rekriteFaz 1
- Willamette Valley Cancer Institute and Research Center, Eugene
MYLUNG Consortium Part 3: Observational Study
Ap rekriteEtid obsèvasyon
- Willamette Valley Cancer Institute and Research Center, Eugene
Etid Kansè poumon nan lòt vil
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Washington, DC41 etid
- Arlington, VA41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
Lòt etid nan Eugene
- Kansè Poumon ki pa ti selil13 etid
- Kansè ovè9 etid
- Kansè Endomèt8 etid
- Kansè nan tete7 etid
- Lukemi lenfositè kwonik6 etid
- Myelom Miltip6 etid
- Kansè Metastatik6 etid
- Kansè (tout kalite)6 etid
- Itilizasyon Dwòg ak Depandans5 etid
- Degeneresans makile5 etid
- Obèsite4 etid
- Kansè pwostat3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.